Crucial real-world insight into treatments chosen by most oncologists for lung cancer patients who tumours have completely resected has now been revealed by a new survey.
Jean Yves Douillard, from the ICO Institut de Cancerologie de l'Ouest Rene Gauducheau, France, Chair of the ESMO Educational Committee, was commenting on a paper published in the journal iLung Cancer/i[1]. In the study, researchers led by Raffaele Califano of The Christie NHS Foundation Trust, Manchester, UK, surveyed 768 ...
Crucial real-world insight into treatments chosen by most oncologists for lung cancer patients who tumours have completely resected has now been revealed by a new survey.
Jean Yves Douillard, from the ICO Institut de Cancerologie de l'Ouest Rene Gauducheau, France, Chair of the ESMO Educational Committee, was commenting on a paper published in the journal iLung Cancer/i[1]. In the study, researchers led by Raffaele Califano of The Christie NHS Foundation Trust, Manchester, UK, surveyed 768 ...